Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain
Clinical trial NCT04707157 · TERMINATED
Trial details
- NCT number
- NCT04707157
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-06
- Primary completion
- 2022-06-13
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.